sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Biopharmaceutical Logistics Market Size Study, By Supply Chain (Cold Chain, Non-Cold Chain), By Services (Transportation Mode, Warehousing, Others), and Regional Forecasts 2024-2032

Global Biopharmaceutical Logistics Market Size Study, By Supply Chain (Cold...

Home / Categories / Automotive
Global Biopharmaceutical Logistics Market Size Study, By Supply Chain (Cold Chain, Non-Cold Chain), By Services (Transportation Mode, Warehousing, Others), and Regional Forecasts 2024-2032
Global Biopharmaceutical Logistics Market Size...
Report Code
RO10/103/1715

Publish Date
06/Nov/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The Global Biopharmaceutical Logistics Market, valued at USD 125.47 billion in 2023, is projected to grow significantly with a CAGR of 5.93% over the forecast period from 2024 to 2032. The growth is driven by the increasing demand for specialized logistics services, particularly for temperature-sensitive biopharmaceuticals, as well as the surge in the production of biologics and vaccines. With an emphasis on ensuring product integrity through the cold chain, logistics providers are increasingly investing in advanced technologies such as IoT sensors, real-time tracking, and AI-powered predictive maintenance systems.

The COVID-19 pandemic highlighted the critical importance of resilient and efficient supply chains in the pharmaceutical industry. This spurred innovation and growth within the biopharmaceutical logistics market as companies and governments sought to improve vaccine distribution and transportation of critical healthcare products. The demand for cold chain logistics, in particular, has expanded as biopharmaceuticals like vaccines, gene therapies, and complex biologics require controlled environments during transit.

North America is expected to dominate the market, benefiting from a well-established pharmaceutical industry and advanced logistics infrastructure. Meanwhile, Asia-Pacific is projected to exhibit the fastest growth, driven by increasing pharmaceutical production, the rise of generics, and improving healthcare infrastructure. The region's expanding cold chain logistics capabilities and investments in technology are fueling its rapid growth.

Key market players include:
DHL International GmbH
United Parcel Service of America Inc.
SF Express
Hitachi Transport System
AmerisourceBergen Corporation
Kerry Logistics Network Limited
Kuehne and Nagel
Agility
DB Schenker
Company 10
The detailed segments and sub-segments of the market are explained below:
By Supply Chain:
Cold Chain
Non-Cold Chain
By Services:
Transportation Mode
Warehousing
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Years considered for the study are as follows:
Historical year: 2022
Base year: 2023
Forecast period: 2024 to 2032
Key Takeaways:
Market estimates and forecasts for 10 years (2024-2032)
Detailed regional analysis with country-level breakdowns
Competitive landscape with information on major market players
Analysis of key strategies and recommendations for future market approaches
Emphasis on technological advancements and their impact on market dynamics

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com